#NewMemberAseBio | “AseBio is the support on which start-ups like Cocoon rely to navigate the commercial and scientific world of our markets”

AseBio. What does your company's work bring to the table and what is its strength?

Romy Dalton. We have the ability to solve the problem of producing recombinant proteins. Recombinant enzymes and growth factors are critical in industries that transform human life, as well as those that have an impact in the environment. On the one hand, our platform offers a viable alternative within the supply process, since our technology allows us to offer products at much lower prices on any type of scale. And, on the other hand, we can produce proteins that are difficult to express and, in some way, mitigate the problem that our clients often face when having to discard a protein due to the impossibility of producing it. Our platform, which is based on the use of chrysalises as natural bioreactors, presents a solution to this dilemma.

AseBio. What is AseBio for you?

Romy Dalton. Spanish biotechnology is firmly rooted at Asebio. It is the support on which start-ups like Cocoon rely to navigate the commercial and scientific world of our markets. The way in which AseBio is organized with all the work groups, and its different activities and proposals, responds to many of the needs that we may have.

AseBio. When did you first hear about AseBio?

Romy Dalton. Many years ago! AseBio has always been a reference as an association to support the biotechnology sector, given its strong expertise, for its efforts in fostering collaboration between its members.

AseBio. What do you expect from being part of an association like AseBio?

Romy Dalton. We hope that by being part of AseBio, we will have the possibility of establishing contacts and collaborations with other companies and organizations related to biotechnology. Likewise, obtain the possibility of strengthening our presence in the sector, contributing to the advancement of science and technology in Spain and taking advantage of all opportunities that this association can offer.

AseBio. What is the biggest challenge facing the biotech sector (or your company)?

Romy Dalton. We have several very clear challenges, on one hand, educating and supporting initiatives related to the future and sustainability within the food supply, and here we see ourselves as pioneers being part of the cultured meat industry. On the other hand, we work with insects, and here we also see ourselves as pioneers since we are introducing totally innovative processes that will allow us to reduce production costs in the supply chain of products related to modifications of mRNA or similar and at the same time through our entomological platform, turn things around, and offer solutions to complicated problems such as the expression of difficult proteins.

We are a young company that seeks to make ourselves known and become a reference in the recombinant protein production industry.